Building global development strategies for cf therapeutics during a transitional cftr modulator era-Reference-Cited by-同舟云学术

Building global development strategies for cf therapeutics during a transitional cftr modulator era

Published:2020-09 Issue:5 Volume:19 Page:677-687
ISSN:1569-1993
Container-title:Journal of Cystic Fibrosis
language:en
Short-container-title:Journal of Cystic Fibrosis

Author:

Mayer-Hamblett N.^ORCID,van Koningsbruggen-Rietschel S.,Nichols D.P.^ORCID,VanDevanter D.R.^ORCID,Davies J.C.^ORCID,Lee T.,Durmowicz A.G.,Ratjen F.^ORCID,Konstan M.W.^ORCID,Pearson K.,Bell S.C.^ORCID,Clancy J.P.,Taylor-Cousar J.L.,De Boeck K.,Donaldson S.H.^ORCID,Downey D.G.,Flume P.A.^ORCID,Drevinek P.^ORCID,Goss C.H.,Fajac I.,Magaret A.S.,Quon B.S.^ORCID,Singleton S.M.,VanDalfsen J.M.,Retsch-Bogart G.Z.

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Pediatrics, Perinatology, and Child Health

Reference59 articles.

1. The future of cystic fibrosis care: a global perspective;Bell;Lancet Respir Med,2020

2. Speeding up access to new drugs for CF: considerations for clinical trial design and delivery;Davies;J Cyst Fibros,2019

3. Developing inhaled antibiotics in cystic fibrosis: current challenges and opportunities;Nichols;Ann Am Thorac Soc,2019

4. Advancing clinical development pathways for new CFTR modulators in cystic fibrosis;Mayer-Hamblett;Thorax,2016

5. Cystic fibrosis: emergence of highly effective targeted therapeutics and potential clinical implications;Mall;Am J Respir Crit Care Med,2019

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Differential times of submission and approval of CFTR modulators for the treatment of Cystic Fibrosis in the United States and the European Union;Journal of Cystic Fibrosis;2024-08

2. Prime editing functionally corrects cystic fibrosis-causing CFTR mutations in human organoids and airway epithelial cells;Cell Reports Medicine;2024-05

3. Inhaled antimicrobial prescribing for Pseudomonas aeruginosa infections in Europe;Journal of Cystic Fibrosis;2024-05

4. Omitting placebos from early-stage clinical trials of cystic fibrosis therapies;Journal of Cystic Fibrosis;2023-12

5. Understanding and addressing the needs of people with cystic fibrosis in the era of CFTR modulator therapy;The Lancet Respiratory Medicine;2023-10